KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.79 $21.89 Friday, 26th Apr 2024 KURA stock ended at $19.65. This is 3.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.01% from a day low at $18.95 to a day high of $19.71.
90 days $16.79 $24.16
52 weeks $7.41 $24.16

Historical Kura Oncology prices

Date Open High Low Close Volume
Feb 14, 2024 $19.91 $20.06 $19.46 $19.73 526 897
Feb 13, 2024 $19.74 $20.01 $19.18 $19.49 923 765
Feb 12, 2024 $19.87 $20.53 $19.86 $20.40 971 012
Feb 09, 2024 $20.49 $21.00 $19.88 $19.97 756 438
Feb 08, 2024 $20.03 $20.61 $19.96 $20.33 1 394 977
Feb 07, 2024 $21.03 $21.03 $20.33 $20.36 478 926
Feb 06, 2024 $20.53 $21.08 $20.26 $20.97 563 873
Feb 05, 2024 $20.88 $20.96 $20.05 $20.55 725 027
Feb 02, 2024 $20.98 $21.45 $20.67 $21.13 926 860
Feb 01, 2024 $20.36 $21.22 $19.91 $21.02 1 134 855
Jan 31, 2024 $21.12 $21.65 $19.98 $20.14 1 865 274
Jan 30, 2024 $18.50 $22.92 $18.24 $20.85 11 186 145
Jan 29, 2024 $17.75 $18.72 $17.45 $18.60 1 496 050
Jan 26, 2024 $18.94 $19.17 $17.91 $17.98 1 758 452
Jan 25, 2024 $19.90 $20.21 $18.66 $18.73 3 210 303
Jan 24, 2024 $18.40 $21.40 $17.82 $19.61 16 022 321
Jan 23, 2024 $14.27 $14.48 $13.29 $13.42 783 348
Jan 22, 2024 $14.79 $14.93 $13.81 $14.00 1 145 491
Jan 19, 2024 $14.52 $14.79 $14.28 $14.69 457 707
Jan 18, 2024 $14.83 $14.84 $14.21 $14.55 568 991
Jan 17, 2024 $14.85 $15.07 $14.48 $14.76 841 138
Jan 16, 2024 $15.19 $15.36 $14.82 $15.17 818 326
Jan 12, 2024 $15.73 $15.95 $15.33 $15.37 733 351
Jan 11, 2024 $14.87 $15.80 $14.79 $15.48 1 345 854
Jan 10, 2024 $14.83 $15.22 $14.57 $15.09 511 124
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT